ATVV Intervention for Parent-Child Relationship
Trial Summary
What is the purpose of this trial?
Childhood adversity affects almost two-thirds of the US population, is a major risk factor for the leading causes of disease and increases US economic health burdens. Childhood adversity also alters biologic systems, such as the oxytocin hormone, that can affect attachment behavior. This innovative study has the potential to advance science and improve mother-infant interaction by testing an early life, home-based, multisensory behavioral intervention (called ATVV), targeting the oxytocin system, to promote synchronous early mother-infant interaction, especially critical for mothers who have experienced childhood adversity.This two-group randomized clinical trial will test the ATVV's effect on oxytocin system function and quality of mother-infant interaction. The investigators will enroll 250 first-time healthy mothers carrying a single baby who have a history of childhood adversity, and obtain baseline data in their third trimester of pregnancy. Soon after birth (before hospital discharge), mothers (and babies) who continue to be eligible are randomized into the intervention group and taught to give ATVV daily for 3 months, or randomized into the Attention Control education group and taught safe infant care. After birth, the investigators check-in frequently with mothers through weekly phone calls. There are 3 study visits at 1, 2 and 3 months after birth that include survey questions and collection of maternal blood and infant saliva. Mothers and babies are also video-recorded at 3 months after birth for 4 minutes to assess mother-infant interaction. The investigators follow-up with a phone call at 6 months after birth.While both groups will benefit from the content and attention the investigators give mothers, the investigators hypothesize that, compared to the education group, mothers and infants in the intervention group will have improved oxytocin system function and more synchronous mother-infant interaction.
Research Team
Aleeca Bell, PhD
Principal Investigator
University of Arizona, College of Nursing
Eligibility Criteria
This trial is for first-time mothers over 18, expecting a single full-term and healthy baby, who have experienced childhood adversity as indicated by an ACE score of 2 or more. They must speak English or Spanish and not be taking antidepressants or illicit drugs during pregnancy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline data collection in the third trimester, including OXT measures and demographic data
Treatment
Participants are randomized into either the ATVV intervention group or the Attention Control group, with daily activities for 3 months
Follow-up
Participants are monitored for the effects of the intervention, including a phone call at 6 months postnatal
Treatment Details
Interventions
- Attention control
- ATVV
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor
Children's Wisconsin
Collaborator